A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans. Despite several emerging vaccines, there remains no verifiable therapeutic targeted specifically to the virus. Here we present a highly effective small interfering RNA (...

Descripción completa

Detalles Bibliográficos
Autores principales: Idris, Adi, Davis, Alicia, Supramaniam, Aroon, Acharya, Dhruba, Kelly, Gabrielle, Tayyar, Yaman, West, Nic, Zhang, Ping, McMillan, Christopher L.D., Soemardy, Citradewi, Ray, Roslyn, O’Meally, Denis, Scott, Tristan A., McMillan, Nigel A.J., Morris, Kevin V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118699/
https://www.ncbi.nlm.nih.gov/pubmed/33992805
http://dx.doi.org/10.1016/j.ymthe.2021.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118699/
https://www.ncbi.nlm.nih.gov/pubmed/33992805
http://dx.doi.org/10.1016/j.ymthe.2021.05.004

Ejemplares similares